Divergent roles of serum CXCL9 as a biomarker in ILD and COPD: a comparative study

20260 citationsJournal Articlegold Open Access

Authors

Chengsheng Yin · Tongji University

Xin Kang · Tongji University

Yong Zhang · Tongji University

Jiacui Song · Tongji University

T. Hasegawa · Sysmex (Germany)

Ling Yao · Sysmex (Japan)

Yang Hu · Tongji University

Abstract

CXCL9 levels correlate with divergent roles in ILD and COPD. It may serve as a prognostic marker, identifying treatable inflammation in ILD and inflammatory burden in COPD.

Topics & Keywords

Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Chronic Obstructive Pulmonary Disease (COPD) Research Chemokine receptors and signaling

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Frontiers in Pharmacology

Volume 17, pp. 1730688-1730688

DOI: 10.3389/fphar.2026.1730688

Field-Weighted Citation Impact: 0.00